Gamers Publish Paper

Players of the online RNA-building game eteRNA publish a set of rules linking an RNA’s shape with the difficulty of synthesizing it.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CARNEGIE MELLON UNIVERSITY, STANFORD UNIVERSITY A team of gamers using eteRNA, an online RNA-building tool, published its initial findings in the Journal of Molecular Biology yesterday (February 16), offering new insights into the relationship between an RNA’s sequence and its structure. Although eteRNA data have been described in previous studies, this is the first time that players of the game—many who are not professional scientists—have led the publication of a scientific article on the subject.

“It’s important to capture these insights and make them both public and credible via publication in peer-reviewed journals,” study coauthor Rhiju Das of Stanford University, who helped create the game, said in a statement.

Das and colleagues launched EteRNA in January 2011 as a way of crowdsourcing human input for a problem that computers were struggling to solve: namely, how to design an RNA sequence that would fold into a particular shape. Players try to construct a sequence of nucleotides that will fold RNA into a configuration specified by the game; once a week, a few molecules are selected by the Stanford researchers and synthesized in the lab to test the game’s predictions.

Now, the gamers’ paper presents a set of rules, compiled principally by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies